Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma

Cancer. 1999 Jan 1;85(1):242-3. doi: 10.1002/(sici)1097-0142(19990101)85:1<242::aid-cncr34>3.0.co;2-r.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use*
  • Cladribine / administration & dosage
  • Cladribine / adverse effects*
  • Cladribine / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Hairy Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Middle Aged
  • Remission Induction

Substances

  • Antineoplastic Agents
  • Cladribine